Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by Engcan77on Oct 25, 2018 11:43am
99 Views
Post# 28871599

RE:RE:RE:RE:Bidsize

RE:RE:RE:RE:BidsizeSo, we have a million shares sitting there waiting for someone who is weak, or frustrated in waiting for results by management. Will they break and give up there investment for 7.5 cents a share! Hopefully they will have to pay more to get on this ride that we will be seeing in the next 12 weeks, and on from there. Let's hope we move higher in speculation on the TFC-1067 Clinical trials, and the hopeful bidding war on the product results. This doesnt mean a company can't jump on board before then, but probably unlikely. Looking back when we were trading around .20 cents for the longest time, and we were not even close to where we are now with the evolution of TFC-1067 and SGLT2. Plus now we have LIP-01. If I were the people sitting their waiting for 7.5 cents, I might be wanting to jump in ther below 10 cents, because they will be looking back, kicking themselves that they didn't pick up more at these ridiculous low prices.
Bullboard Posts